Effects of smoking cessation, acute re-exposure and nicotine replacement in smokers on AIR® inhaled insulin pharmacokinetics and glucodynamics

British Journal of Clinical Pharmacology

Volumn 65, Issue 4, 2008, Pages 480-487

  Pan, Alan X ^a   De La Peña, Amparo ^b   Yeo, Kwee P ^a   Chan, Clark ^a   Loh, Mei T ^a   Wise, Stephen D ^a   Silverman, Bernard L ^c   Muchmore, Douglas B ^b  

^a NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^b ELI LILLY AND COMPANY   (United States)

^c ALKERMES INC   (United States)

Author keywords

Acute re exposure; Glucodynamics; Inhaled insulin; Nicotine replacement therapy; Pharmacokinetics; Smoking cessation

Indexed keywords

AIR INSULIN; GLUCOSE; INSULIN; INSULIN LISPRO; NICOTINE; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COUGHING; DIZZINESS; DOSE RESPONSE; FEMALE; GLUCOSE CLAMP TECHNIQUE; GLUCOSE METABOLISM; HUMAN; HUMAN EXPERIMENT; INSULIN METABOLISM; LUNG FUNCTION; MALE; NICOTINE REPLACEMENT THERAPY; NORMAL HUMAN; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENCE RISK; RHINORRHEA; SMOKING CESSATION;

EID: 40549137176     PISSN: 03065251     EISSN: 13652125     Source Type: Journal    
DOI: 10.1111/j.1365-2125.2007.03041.x     Document Type: Article

References (21)

1. 1 Muchmore DB, Gates JR. Inhaled insulin delivery–where are we now? Diabetes Obes Metab 2006 ; 8: 634–42.
2. 2 Lenzer J. Inhaled insulin is approved in Europe and United States. BMJ 2006 ; 332: 321.
3. 3 Jones JG, Minty BD, Lawler P, Hulands G, Crawley JC, Veall N. Increased alveolar epithelial permeability in cigarette smokers. Lancet 1980 ; 1: 66–8.
4. 4 Himmelmann A, Jendle J, Mellen A, Petersen AH, Dahl UL, Wollmer P. The impact of smoking on inhaled insulin. Diabetes Care 2003 ; 26: 677–82.
5. 5 Wise S, Chien J, Yeo K, Richardson C. Smoking enhances absorption of insulin but reduces glucodynamic effects using the Lilly/Dura inhaled insulin system. Diabet Med 2006 ; 23: 510–5.
6. 6 Becker RHA, Sha S, Frick AD, Fountaine RJ. The effect of smoking cessation and subsequent resumption on absorption of inhaled insulin. Diabetes Care 2006 ; 29: 277–82.
7. 7 Mason GR, Uszler JM, Effros RM, Reid E. Rapidly reversible alterations of pulmonary epithelial permeability induced by smoking. Chest 1983 ; 83: 6–11.
8. 8 Kohler D, Schluter KJ, Kerp L, Matthys H. Nicht radioaktives Verfahren zur Messung der Lungenpermeabilitat: Inhalation von Insulin. Atemw-Lungenkrkh 1987 ; 13: 230–2.
9. 9 Minty BD, Jordan C, Jones JG. Rapid improvement in abnormal pulmonary epithelial permeability after stopping cigarettes. BMJ 1981 ; 282: 1183–6.
10. 10 Edwards DA, Hanes J, Caponetti G, Hrkach J, Ben‐Jebria A, Eskew ML, Mintzes J, Deaver D, Lotan N, Langer R. Large porous particles for pulmonary drug delivery. Science 1997 ; 276: 1868.
11. 11 Axelsson T, Jansson PA, Smith U, Eliasson B. Nicotine infusion acutely impairs insulin sensitivity in type 2 diabetic patients but not in healthy subjects. J Intern Med 2001 ; 249: 539–44.
12. 12 Eliasson B, Taskinen MR, Smith U. Long‐term use of nicotine gum is associated with hyperinsulinemia and insulin resistance. Circulation 1996 ; 94: 878–81.
13. 13 Rave KM, Nosek L, De La Peña A, Seger M, Ernest CS II, Heinemann L, Batycky RP, Muchmore DB. Dose–response and dose equivalency of human insulin inhalation powder (HIIP) using the Lilly/Alkermes inhaled insulin system compared to subcutaneous (sc) insulin lispro. Diabetes Care 2005 ; 28: 2400–5.
14. 14 DeFronzo RA, Tobin JD, Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 1979 ; 237: E214–23.
15. 15 Sha S, Becker RHA, Willavise SA, Schumacher DA, Lee JD, Carroll RS, Fryburg DA. The effect of smoking cessation on the absorption of inhaled insulin (Exubera). Diabetes 2002 ; 51 (Suppl. 2): A133.
16. 16 Wilkes S, Evans A. A cross‐sectional study comparing the motivation for smoking cessation in apparently healthy patients who smoke to those who smoke and have ischaemic heart disease, hypertension or diabetes. Fam Pract 1999 ; 16: 608–10.
17. 17 Assali AR, Beigel Y, Schreibman R, Shafer Z, Fainaru M. Weight gain and insulin resistance during nicotine replacement therapy. Clin Cardiol 1999 ; 22: 357–60.
18. 18 Chalon S, Moreno H Jr, Benowitz NL, Hoffman BB, Blaschke TF. Nicotine impairs endothelium‐dependent dilatation in human veins in vivo. Clin Pharmacol Ther 2000 ; 67: 391–7.
19. 19 Mayhan WG, Sharpe GM. Chronic exposure to nicotine alters endothelium‐dependent arteriolar dilatation: effect of superoxide dismutase. J Appl Physiol 1999 ; 86: 1126–34.
20. 20 Goldman MD. Lung dysfunction in diabetes. Diabetes Care 2003 ; 26: 1915–8.
21. 21 Davis WA, Knuiman M, Kendall P, Grange V, Davis TME. Glycemic exposure is associated with reduced pulmonary function in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care 2004 ; 27: 752–7.